Skip to search.
 FTSE 100 Up 0.42%
Streaming
Ticker Tape: On

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
8.41 Down 0.14(1.64%) 24 Apr 21:00
Add to Portfolio
Prev Close:8.55
Open:8.60
Bid:7.90 x 1000
Ask:8.64 x 1000
1y Target Est:16.00
Beta:3.21
Next Earnings Date: 8-May-14BCRX Earnings announcement
Day's Range:7.87 - 8.74
52wk Range:1.42 - 13.33
Volume:885,418
Avg Vol (3m):1,058,130
Market Cap:499.42m
P/E (ttm):N/A
EPS (ttm):-0.55
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):29.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.75
Quarterly EPS Est (Mar-14) :-0.17
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):-2.12

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback